If any symptoms persist or worsen, or you notice any other symptoms, please call your doctor
This article explains the clinical principles behind reconstitution, the significant safety risks of self-administering unlicensed injectables, and why individuals considering retatrutide should seek guidance from a qualified healthcare professional before proceeding
Supports gastrointestinal healing (such as repairing leaky gut or ulcers)
AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection
There are risks for maternal, fetal, and neonatal toxicity
It's a strategy that attempts to get the best of both worldsthe full-body benefits of systemic administration with a localized boost